Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2000
05/18/2000WO2000027874A2 Nucleic acids encoding transferrin receptor-like proteins and products related thereto
05/18/2000WO2000027873A2 Interleukin-2 binding protein from arthropods
05/18/2000WO2000027872A1 Sensor protein and utilization thereof
05/18/2000WO2000027871A2 New family of mammalian potassium channels, their cloning and their use, especially for the screening of drugs
05/18/2000WO2000027870A1 Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
05/18/2000WO2000027869A1 Methods of purifying recombinant human erythropoietin from cell culture supernatants
05/18/2000WO2000027868A2 Connective tissue growth factor (ctgf) and methods of use
05/18/2000WO2000027866A1 Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
05/18/2000WO2000027865A1 CHARACTERIZATION OF NOVEL GENE cbl-SL
05/18/2000WO2000027864A1 CHROMOSOME 17p-LINKED PROSTATE CANCER SUSCEPTIBILITY GENE
05/18/2000WO2000027863A1 Dna molecules encoding the melanocortin 4 receptor protein from rhesus monkey
05/18/2000WO2000027862A1 Dna molecules encoding the melanocortin 3 receptor protein from rhesus monkey
05/18/2000WO2000027861A1 Novel phosphodiesterase interacting proteins
05/18/2000WO2000027814A1 Avidin derivatives and uses thereof
05/18/2000WO2000027432A1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS
05/18/2000WO2000027431A1 Method of treating arthritis with human parvovirus b19 antigens or antibodies against same
05/18/2000WO2000027429A2 Vaccine against papillomatous digital dermatitis (pdd)
05/18/2000WO2000027422A2 Methods and compositions for treating or preventing peripheral neuropathies
05/18/2000WO2000027416A1 Stimulation of angiogenesis via syndecan-4 cytoplasmic domain signaling pathway
05/18/2000WO2000027415A2 Inhibition of angiogenesis by peptide analogs of high molecular weight kininogen domain 5
05/18/2000WO2000027414A2 Inhibition of the formation of vascular hyperpermeability
05/18/2000WO2000027205A1 A recombinant polypeptide for use in the manufacture of vaccines against campylobacter induced diarrhea and to reduce colonization
05/18/2000WO2000027198A1 Retroviral vectors encoding interferon alpha and uses thereof
05/18/2000WO2000011890A3 METHODS FOR ISOLATING RECOMBINANT β-CASEIN
05/18/2000WO2000009734A3 Methods and compositions for use in spliceosome mediated rna trans-splicing
05/18/2000WO2000009730A3 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins
05/18/2000WO2000009725A3 Method for recovering proteins from the interstitial fluid of plant tissues
05/18/2000WO2000009720A3 Cytochrome b5 from petunia
05/18/2000WO2000009714A9 Overexpression of desired proteins in eukaryotic cells mediated by cyclin d1 overexpression
05/18/2000WO2000009699A3 Method for producing yeast expressed hpv types 6 and 16 capsid proteins
05/18/2000WO2000009658A3 Gene regulating circadian clock function and photoperiodism
05/18/2000WO2000009655A3 Genes amplified in cancer cells
05/18/2000WO2000009553A3 Antimicrobial peptides isolated from the skin of american frogs
05/18/2000WO2000008181A3 Chp polypeptide, a ligand of pak65
05/18/2000WO2000008141A3 Short oligonucleotides for the inhibition of vegf expression
05/18/2000WO2000008057A3 Molecules designated b7l-1
05/18/2000WO2000002916B1 PEPTIDE COMPOSITIONS MIMICKING TGF-β ACTIVITY
05/18/2000WO2000002910A9 Human fast-1 gene
05/18/2000WO2000000829A9 Method and composition to detect c-type retroviral infection
05/18/2000WO2000000514A3 Synthetic spiroketal pyranes as potent anti-cancer agents
05/18/2000WO1999061467A3 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins
05/18/2000WO1999060014A3 Methods and compounds for modulating nuclear receptor coactivator binding
05/18/2000WO1999052415A3 Therapeutics and diagnostics for congenital heart disease based on a novel human transcription factor
05/18/2000WO1999024470A8 Mammalian milk growth factor
05/18/2000DE19852757A1 Promotoren zur Genexpression in Wurzeln von Pflanzen Promoters for gene expression in roots of plants
05/18/2000DE19852729A1 Rekombinante Glycoproteine, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und ihre Verwendung Recombinant glycoproteins, processes for their preparation, pharmaceutical compositions containing them and their use
05/18/2000DE19852195A1 Neue Expressionskassette zur Expression von beliebigen Genen in Pflanzensamen New expression cassette for expression of any genes in plant seeds
05/18/2000DE19850718C1 Zellpermeabilität-vermittelndes Polypeptid Cell permeability-mediating polypeptide
05/18/2000CA2704598A1 Methods of purifying recombinant human erythropoietin from cell culture supernatants
05/18/2000CA2351167A1 Nucleic acids and polypeptides having altered expression in the t84 gut barrier model
05/18/2000CA2351145A1 Vaccine against papillomatous digital dermatitis (pdd)
05/18/2000CA2351019A1 Htfiiia human gene and coded htfiiia protein
05/18/2000CA2351017A1 Catfiiia candida albicans tfiiia gene (catfiiia) and the coded catfiiia protein
05/18/2000CA2350915A1 Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
05/18/2000CA2350827A1 Screening system for zinc finger polypeptides for a desired binding ability
05/18/2000CA2350775A1 Chlamydia pneumoniae genome sequence
05/18/2000CA2350771A1 Chemokine .beta.-7
05/18/2000CA2350621A1 Human secretory protein-61
05/18/2000CA2350339A1 Pholasin
05/18/2000CA2350335A1 Host cells expressing recombinant human erythropoietin
05/18/2000CA2350334A1 New family of mammalian potassium channels, their cloning and their use, especially for the screening of drugs
05/18/2000CA2350183A1 Use of an enterobacterium protein ompa for specific targeting towards antigen-presenting cells
05/18/2000CA2350182A1 Connective tissue growth factor (ctgf) and methods of use
05/18/2000CA2350169A1 Dna molecules encoding the melanocortin 4 receptor protein from rhesus monkey
05/18/2000CA2350122A1 Method for the massive culture of cells producing recombinant human erythropoietin
05/18/2000CA2350087A1 Chromosome 17p-linked prostate cancer susceptibility gene
05/18/2000CA2350086A1 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor
05/18/2000CA2349951A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof
05/18/2000CA2349950A1 Dna molecules encoding the melanocortin 3 receptor protein from rhesus monkey
05/18/2000CA2349848A1 Dna molecules encoding the melanocortin 5 receptor protein from rhesus monkey
05/18/2000CA2349815A1 Human cell surface receptor proteins
05/18/2000CA2349814A1 Cytokine signal regulators
05/18/2000CA2349761A1 Corticosteroid synthesis-associated genes
05/18/2000CA2349720A1 Stimulation of angiogenesis via syndecan-4 cytoplasmic domain signaling pathway
05/18/2000CA2349679A1 Modified exosomes and uses
05/18/2000CA2349527A1 Enzymatic amidation of peptides
05/18/2000CA2349498A1 Methods and compositions for treating or preventing peripheral neuropathies
05/18/2000CA2349496A1 Delivery of superoxide dismutase to neuronal cells
05/18/2000CA2349449A1 Cell surface glycoproteins
05/18/2000CA2349437A1 Hypersensitive response elicitor-induced stress resistance
05/18/2000CA2349159A1 Activity dependent neurotrophic factor iii (adnf iii)
05/18/2000CA2348775A1 Method to control gene expression in bacteria, namely rhizobiaceae, to improve root nodule development, nitrogen fixation and plant biomass production
05/18/2000CA2348699A1 Virulence genes and proteins, and their use
05/18/2000CA2348685A1 Biomarkers for oxidative stress
05/18/2000CA2348382A1 Chimeric parvovirus vectors and methods of making and administering the same
05/18/2000CA2348308A1 Rantes-derived peptides with anti-hiv activity
05/18/2000CA2347916A1 Inhibition of the formation of vascular hyperpermeability
05/18/2000CA2347847A1 A method of treating tumors using fas-induced apoptosis
05/18/2000CA2346962A1 Fk506-based regulation of biological events
05/18/2000CA2345351A1 Disease resistance factors
05/17/2000EP1001032A2 Recombinant retroviruses delivering vector constructs to target cells
05/17/2000EP1001031A1 Parvovirus-vectors and their use
05/17/2000EP1001030A1 Recombinant CELO virus and CELO virus DNA
05/17/2000EP1001025A2 Outer membrane proteins from actinobacillus pleuropneumoniae
05/17/2000EP1001024A2 Protein encoded by the trkB proto-oncogene, used in assay systems for neurothophin activity
05/17/2000EP1001023A2 Frizzled-4, a putative Wnt-receptor
05/17/2000EP1001022A1 CAMEL, an alternative translation product of the tumour antigen LAGE-1
05/17/2000EP1001019A1 Transgenic animals harboring APP Allele having Swedish mutation
05/17/2000EP1001016A1 ANTI-$i(VIBRIO ANGUILLARUM) VACCINE (GAVA-3) FOR THE PREVENTION OF THE VIBRIOSIS DISEASE IN THE TURBOT AND SALMONIDAE, AND PREPARATION PROCESS
05/17/2000EP1000628A1 Use of antigenic complexes of HIV envelope and HLA class I antigens as HIV vaccine
1 ... 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 2178 2179 2180 ... 2916